Cargando…

Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

Qingyihuaji formula (QYHJ), confirmed efficacious in a series of clinical trials, has been applied to human pancreatic carcinoma treatment in Shanghai Cancer Center for years. Recent evidence highlighted that pluripotent stem cells transcription factor Nanog plays a pivotal role in carcinogenesis. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Song, Pan, Yan, Song, Libin, Dong, Lei, Weng, Lao I., Wang, Peng, Hua, Yongqiang, Chen, Zhen, Liu, Luming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086502/ https://www.ncbi.nlm.nih.gov/pubmed/27829864 http://dx.doi.org/10.1155/2016/7028289

Ejemplares similares

Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
por: Xu, Yanli, et al.
Publicado: (2015)

Retracted: Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
por: Alternative Medicine, Evidence-Based Complementary and
Publicado: (2021)

Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals
por: Chen, Peng, et al.
Publicado: (2019)

ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer
por: Gao, Song, et al.
Publicado: (2015)

Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network
por: Qian, Xiang, et al.
Publicado: (2020)

SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG
por: Tan, Peng, et al.
Publicado: (2019)

High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway
por: HUA, YONG-QIANG, et al.
Publicado: (2014)

MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
por: Xu, Jianwei, et al.
Publicado: (2014)

The Herbal Formula JI017 Induces ER Stress via Nox4 in Breast Cancer Cells
por: Kim, Tae Woo, et al.
Publicado: (2021)

BaBao Dan Suppresses Tumor Growth of Pancreatic Cancer Through Modulating Transcriptional Reprogramming of Cancer-Related Genes
por: Song, Libin, et al.
Publicado: (2020)

Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer
por: Kikuyama, Masataka, et al.
Publicado: (2018)

Cyclohexylmethyl Flavonoids Suppress Propagation of Breast Cancer Stem Cells via Downregulation of NANOG
por: Liao, Wen-Ying, et al.
Publicado: (2013)

Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancer
por: Arima, Kota, et al.
Publicado: (2018)

Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer
por: Yu, Haibo, et al.
Publicado: (2019)

The Identification of the Biomarkers of Sheng-Ji Hua-Yu Formula Treated Diabetic Wound Healing Using Modular Pharmacology
por: Jiang, Jing-Si, et al.
Publicado: (2021)

Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog
por: Ma, Yiming, et al.
Publicado: (2019)

Identification of Upregulated HNRNPs Associated with Poor Prognosis in Pancreatic Cancer
por: Qiao, Lu, et al.
Publicado: (2019)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer
por: Yang, Caiting, et al.
Publicado: (2016)

SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer
por: Aghamaliyev, Ughur, et al.
Publicado: (2023)

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer
por: Wang, Feng-Jiao, et al.
Publicado: (2021)

Mahatma Gandhi Ji kai!
por: Godoy, Emma
Publicado: (1969)

Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer
por: Yu, Mengsi, et al.
Publicado: (2021)

NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
por: Saga, Kotaro, et al.
Publicado: (2019)

Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer
por: Song, Libin, et al.
Publicado: (2021)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer
por: Wang, Shujie, et al.
Publicado: (2021)

Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer
por: Khojasteh-Leylakoohi, Fatemeh, et al.
Publicado: (2023)

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)

Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2014)

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
por: Owusu-Ansah, Kwabena Gyabaah, et al.
Publicado: (2019)

The contributions of hypoxia to poor outcomes in pancreatic cancer
por: Bijlsma, Maarten F.
Publicado: (2022)

She Ji: The Next Five Years
por: Friedman, Ken, et al.
Publicado: (2020)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021)

Increased expression of αTubulin is associated with poor prognosis in patients with pancreatic cancer after surgical resection
por: Lin, Chao, et al.
Publicado: (2016)

Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer
por: Niu, Zheyu, et al.
Publicado: (2015)

High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
por: Ohkuma, Ryotaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t8e7jq44ngcvm8le5mdge5stdl